It was first suggested by Smithers in 19591 that myasthenia gravis might be an autoimmune disease because of the histological similarities he noticed between the thymus gland in myasthenic patients and the thyroid gland in patients with thyroiditis. Within a short period of time several other workers reported immunological features in the disorder: Nastuk and co-workers2 3 provided the first laboratory evidence of an immunological abnormality when they enlarged on work first reported in 19564 and recorded changes in the serum complement levels of myasthenic subjects; at the same time Strauss et a15 reported the presence of complement-fixing antibody, binding in vitro to skeletal muscle, in the serum of these patients. Simultaneously, Simpson6 described a very large series of cases of myasthenia gravis and drew attention to the increased incidence of other illnesses thought to be autoimmune. Thus the attention of the early investigators of myasthenia gravis was drawn to the immune system and since then a voluminous literature of immunological observations has accrued in this disorder.
A wide variety of immunological abnormalities have been demonstrated including evidence of thymus-derived (T cell) malfunction in vivo and in vitro, changes in the distribution of T and bursa-derived (B) lymphocytes in the thymus gland, a wide variety of autoantibodies with, in particular, antibodies to the nicotinic postsynaptic acetylcholine receptor, fluctuations of certain serum complement components, and the presence of circulating immune complexes.
A genetic contribution to the pathogenesis of the disease has also been clearly demonstrated by family studies and, more recently, by the discovery that certain histocompatibility antigens are over-represented in these patients. Finally, a laboratory model, experimental allergic myasthenia gravis (EAMG) , produced by immunising susceptible animals with postsynaptic nicotinic receptor, has been described.
It is stressed in this article that immunoregulation, which is dependent on the proper interaction of genetic and extrinsic factors, is abnormal in myasthenia gravis and the plethora of immunological abnormalities found can thus be interpreted as due to a central defect in immune regulation.
T lymphocyte function It seems appropriate to begin this section with restatement of the fact that led Simpson" to formulate his theory that myasthenia gravis was an autoimmune disorder: that is, there is an association of myasthenia gravis with several other diseases considered to have an autoimmune aetiology. The has been suggested in fact that defective functioning of this subgroup underlies autoimmune disease.30
There have been some studies of suppressor cell activity in myasthenia gravis and an increase in the number of these cells has been reported. 31 As explained however, theoretically one would expect a decrease in the suppressor cell population. 32 33 Work has been done on other subgroups of T cells in childhood myasthenia gravis: investigators have detected a serum factor directed at a subpopulation of the T lymphocytes and associated with a decrease in the total number of T cells, as identified by the E-rosette technique. 34 Their results are in direct contrast to those of the numerous other workers who have not found any significant difference in the proportion of E-rosetting cells found in adult myasthenics or normal controls.18 20 21 23 24 Animal studies have helped to illuminate the major role played by suppressor cells in the immune system and it is these studies which have suggested that autoimmunity is due to a functional deficiency of such lymphocytes. Conditions which cause impairment of central T cell regulation result in hyperactivity of B cells and the production of autoantibodies.
One of the most extensively studied models of such a disorder is the autoimmune condition found in New Zealand black (NZB) mice, or in the hybrid produced by crossing New Zealand black and white (NZB/W) mice. The murine model of autoimmunity which develops is very similar to human systemic lupus erythematosus, with hyperglobulinaemia. Coombs-positive haemolytic anaeemia, antinuclear and lymphocyto toxic antibodies and immune complex glomerulonephritis. 35 Autoimmune phenomena develop with age and it has been shown that when old mice are injected with the T cells of young mice there is some reduction in the severity of the immunological disorders. 35 Since it has been suggested that this development of autoimmunity reflects loss of suppressor cell activity, confirmation of the hypothesis was sough,t by treating mice, from the first month of age, with the soluble products of concanavallin A stimmulated suppressor T lymphocytes. The treated animals were shown to have hypogammaglobulinaemia, no antinuclear or antierythrocytic antilbodies and the immune complex nephritis found was very much milder than in the untreated group, that is "whereas 96% of the untreated animals developed pathologic glomerular lesions, of 2 to 4+ severity, only 4% of the treated animals developed a renal abnormality of this magnitude".33 A marked prolongation of survival in the treated mice was also noticed.
A utoantibodies As discussed in the preceding paragraphs there is now conclusive evidence of T cell abnormalities in patients with myasthenia gravis. These abnormalities, especially those of immunoregulation, lead to the vast array of immunologic aberrations found in the disorder. Numerous autoantibodies have been detected in myasthenic serum with the recent demonstration of antibody to the postsynaptic nicotinic acetylcholine receptor affording us a major insight into the pathogenesis of the disease (see Antibodies to skeletal muscle are also detectable in the first degree relatives of these patients. 86 The family studies cited here do not point to any obvious mode of inheritance: recessive transmission is unlikely because parents, second and third degree relatives may have the disorder and dominant inheritance is militated against because of the skipping of generations.
Twin studies The study of twins offers a unique method of evaluating the role of genetic and environmental factors in any disease as observed originally by Sir Francis Galton in his classical study. Myasthenia gravis has been reported in 15 pairs of monozygotic twins (table 4) with concordance of the disease in five of the female pairs and one of the male pairs. In the remaining nine sets of twins, only one had the disease. These reports are in contrast to the studies in fraternal twins, where of the nine cases studied, concordance was not present in any. Four of those affected were girls, two with unaffected brothers and two with unaffected sisters. One of the twin sisters with myasthenia gravis whose brother did not have the disease, did in fact have Further confirmation of the striking relationship between HLA-B8 and myasthenia gravis was obtained by an analysis of 56 cases which included seven Negro and Indian patients. 47 In these two races HLA-B8 is quite uncommon yet the three young females were all HLA-B8 positive. Patients in the group were also subdivided on the basis of their thymic pathology. Although the number of cases was small it appeared that it was females with thymic hyperplasia in whom the association with HLA-B8 was cxpressed (nine of 16 cases), not those with a thymoma.
This work was confirmed in the 1977 histocompatibility workshop'03 where HLA antigens and thymic pathology were compared in 106 Naeim et al,'117 in another study did suggest that there was such a relationship between antibody titre and the possession of B8 antigen but their data was weakened by the small number of patients and the conflicting data in some of their tables.
The increased incidence of HLA B8 antigen in myasthenia gravis may hold true for Caucasians but not for all other races. It does not seem to be the case in Japan where a study of Japanese myasthenics revealed an increased association of HLA B12 especially in young females with early disease and thymic hyperplasia.108 These workers also found HLA B5 was increased in patients with thymoma.
Experimental allergic myasthenia gravis (EA MG) The animal model for myasthenia gravis has been studied in various species including the mouse,109 rat,40 monkey,"' rabbit"2 and guinea-pig"0 but there have been few studies of the genetic factors involved. The tentative conclusions reached, therefore, do not allow us to determine the exact role of the histocompatibility complex in the experimental disease. One group of workers'09 has shown that the susceptibility of inbred mouse strains to the disease correlates with the H-2 haplotype possessed by the strain, but it could be argued that their inoculation procedurc was not the best available. The definitive experiments, are those in which congenic strains of mice (i.e. those differing genetically only at the H-2 locus) are used, since these will help to define the importance of histocompatibility types in the course of 'the disease. These studies are described by Lennon in this P 0 Behan Festschrift.
The results of experiments being carried out at present in our own laboratory suggest that EAMG in the rat, as evaluated electrophysiologically by the measurement of miniature endplate potentials in isolated rat diaphragms in vitro, is related to the major histocompatibility antigen. Our preliminary studies in this species have revealed an association between the titre of acetylcholine receptor antibody and certain histocompatibility loci. The genetic data reported thus help to confirm the resemblance between EAMG and human myasthenia gravis.
